CCI Approves Mankind Pharma’s Acquisition of Bharat Serums and Vaccines in Rs 13,630 Crore Deal
In a significant development for the Indian pharmaceutical industry, the Competition Commission of India (CCI) has officially approved Mankind Pharma Ltd’s acquisition of Bharat Serums and Vaccines Limited (BSV). This acquisition, valued at Rs 13,630 crore, marks a major strategic move for Mankind Pharma, the fourth-largest pharmaceutical company in India by market share. The proposed …